These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Author: Hutchins DA, Rogers KJ.
    Journal: Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287.
    Abstract:
    1. An increase in the concentration of glycogen occurs in the mouse brain after depletion of cerebral catecholamines by alpha methyl-p-tyrosine methylester (H44/68), diethyldithiocarbamate, or reserpine.2. Depletion of cerebral 5-hydroxytryptamine with parachlorophenylalanine (PCPA) does not result in a change in the concentration of brain glycogen.3. When H44/68 is administered together with reserpine to inhibit the synthesis and storage of cerebral catecholamines, and thus bring about their total depletion from the brain, the cerebral glycogenolytic effect of amphetamine is abolished.4. Amphetamine-inducing glycogenolysis is only partially antagonized if only one of the catecholamine-depleting agents H44/68, diethyldithiocarbamate, or reserpine is injected prior to the amphetamine. The persistence of this glycogenolytic effect of amphetamine is possibly due to the presence of residual stores of catecholamines available for release by the stimulant drug.5. Depletion of cerebral 5-hydroxytryptamine by PCPA does not result in any antagonism of amphetamine-induced glycogenolysis.6. The results suggest that amphetamine depletes brain glycogen by the release of central catecholamines rather than by a direct action at receptors.
    [Abstract] [Full Text] [Related] [New Search]